Pippa Corrie

Cambridge University Hospitals NHS Foundation Trust

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

John Bridgewater

UCL Cancer Institute

UNITED KINGDOM

View details

Darius Mirza

Professor of HPB Surgery and Transplantation

University Hospitals Birmingham NHS Foundation Trust

UNITED KINGDOM

View details

Tarek Meniawy

University of Western Australia

AUSTRALIA

View details

Allison Betof Warner

Assistant Professor, Director of Melanoma Medical Oncology, Director of Solid Tumor Cellular Therapy

Stanford University

UNITED STATES

View details

Raj Prasad

Professor of Surgery, Section Chief of Liver Transplantation

Medical College of Wisconsin

UNITED STATES

View details

Christopher Jones

Clinical Lecturer

University of Cambridge

UNITED KINGDOM

View details

Céleste Lebbé

Université Paris Cité

FRANCE

View details

Doreen Lau

Lecturer (Assistant Professor)

Brunel University London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pippa Corrie

Research Interests

Explore related searches

Contact this professor

Articles (11)

Curing Stage IV Melanoma: Where Have We Been and Where Are We?

First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401

Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future

Revitalising cancer clinical trials: definitely time for patient-centred reform

Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy

MRI techniques for immunotherapy monitoring

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study

Reply to Comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”

Ocular adverse events associated with immune checkpoint inhibitors: a novel multidisciplinary management algorithm

Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma

Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position

Collaborators (8)

John Bridgewater

Darius Mirza

Tarek Meniawy

Allison Betof Warner

Raj Prasad

Christopher Jones

Céleste Lebbé

Doreen Lau

Make your next move.